Morning Briefing
Summaries of health policy coverage from major news organizations
NIAID Launches Clinical Trials Of Dengue Vaccine
After more than a decade of development, the National Institute of Allergy and Infectious Diseases (NIAID) has started clinical trials to test a vaccine to protect against the dengue virus, a product researchers hope may one day "help prevent a disease to which 2.5 billion people are exposed," CIDRAP News reports (Roos, 8/9).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
